1. Home
  2. CPOP vs NNVC Comparison

CPOP vs NNVC Comparison

Compare CPOP & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pop Culture Group Co. Ltd

CPOP

Pop Culture Group Co. Ltd

HOLD

Current Price

$0.29

Market Cap

18.8M

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.76

Market Cap

21.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPOP
NNVC
Founded
2007
2005
Country
China
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
21.2M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
CPOP
NNVC
Price
$0.29
$1.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
48.2K
481.0K
Earning Date
11-17-2025
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.85
52 Week High
$2.60
$2.23

Technical Indicators

Market Signals
Indicator
CPOP
NNVC
Relative Strength Index (RSI) 50.04 63.87
Support Level $0.21 $1.35
Resistance Level $0.35 $1.87
Average True Range (ATR) 0.03 0.16
MACD -0.00 0.00
Stochastic Oscillator 60.76 76.90

Price Performance

Historical Comparison
CPOP
NNVC

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: